Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

NCT01250210 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovulation Suppression

Interventions

DRUG: levonorgestrel and ethinyl estradiol

Sponsor

Agile Therapeutics